Most recently Salehi Khesht et al. designed chitosan lactate nanoparticles targeted with (NPs) HIV-1 derived TAT peptide to deliver CD73 siRNA and doxorubicin to 4T1 and CT26 cancer cells. This evidence concerns the gene NT5E and cancer.